JP Morgan Downgrades Agilon Health to Underweight, Announces $21 Price Target

Benzinga Newsdesk www.benzinga.com Negative 89.9%

Neg 89.9% Neu 0% Pos 0%

JP Morgan analyst Lisa Gill downgrades Agilon Health (NYSE:AGL) from Neutral to Underweight and announces $21 price target.